Cetera Investment Advisers
CGTX icon

Cetera Investment Advisers’s Cognition Therapeutics CGTX Stock Holding History

Cetera Investment Advisers’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.3K Hold
41,150
– – ﹤0.01% 4627
2025
Q4 		$55.6K Sell
41,150
-19,000
-32% -$30.8K ﹤0.01% 4492
2025
Q3 		$81.2K Buy
60,150
+49,800
+481% +$67.9K ﹤0.01% 4367
2025
Q2 		$3.21K Buy
+10,350
New +$3.49K ﹤0.01% 4065

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Cetera Investment Advisers's CGTX Position: Q1 2026 in Review

Cetera Investment Advisers held its Cognition Therapeutics (CGTX) position steady in Q1 2026 at 41,150 shares worth $31.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4627.

Cetera Investment Advisers first reported a position in CGTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $81.2K in Q3 2025. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

  • Cetera Investment Advisers held 41,150 shares of Cognition Therapeutics worth $31.3K as of Q1 2026.
  • Cetera Investment Advisers left its Cognition Therapeutics share count unchanged in Q1 2026.
  • Cognition Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4627 holding.
  • Cetera Investment Advisers first reported a position in Cognition Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Cetera Investment Advisers's Cognition Therapeutics position peaked at $81.2K in Q3 2025.
  • 75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.